NexaBiome Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Liquidation

NexaBiome General Information

Description

Developer of a bacteriophage immobilization and stabilization technology designed to treat infections and bacterial contamination. The company's technology develops products for the treatment and prevention of infection and bacterial contamination in medicine, food safety, environmental sanitation and many other areas, enabling doctors and partners to get potent anti-infectives that target and destroy specific bacteria but are harmless to plants, animals and humans.

Contact Information

Website
www.nexabiome.com
Formerly Known As
Fixed Phage
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • West of Scotland Science Park Block 2
  • Kelvin Campus, 2317 Maryhill Road
  • Glasgow G20 0SP
  • Scotland, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, AgTech, TMT
Corporate Office
  • West of Scotland Science Park Block 2
  • Kelvin Campus, 2317 Maryhill Road
  • Glasgow G20 0SP
  • Scotland, United Kingdom

NexaBiome Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NexaBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Bankruptcy: Liquidation 09-May-2025 Completed Bankruptcy: Liquidation
12. Later Stage VC 01-May-2024 Completed Generating Revenue
11. Later Stage VC 14-Dec-2022 Completed Generating Revenue
10. Secondary Transaction - Private Completed Generating Revenue
9. Later Stage VC 15-Mar-2021 Completed Generating Revenue
8. Later Stage VC 23-Apr-2018 Completed Generating Revenue
7. Later Stage VC 14-Jul-2016 Completed Generating Revenue
6. Grant 01-Dec-2015 Completed Generating Revenue
5. Seed Round 12-Jun-2013 $97.9K Completed Startup
4. Early Stage VC 16-Aug-2012 $97.9K Completed Startup
To view NexaBiome’s complete valuation and funding history, request access »

NexaBiome Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
A Ordinary
To view NexaBiome’s complete cap table history, request access »

NexaBiome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bacteriophage immobilization and stabilization technology designed to treat infections and bacterial cont
Biotechnology
Glasgow, United Kingdom
13 As of 2024

Dundee, United Kingdom
 

Labege, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NexaBiome Competitors (25)

One of NexaBiome’s 25 competitors is APS Biocontrol, a Corporation company based in Dundee, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
APS Biocontrol Corporation Dundee, United Kingdom
Vaiomer Accelerator/Incubator Backed Labege, France
Gangagen Biotechnologies Venture Capital-Backed Bangalore, India
NovaBiotics Venture Capital-Backed Aberdeen, United Kingdom
Second Genome Formerly VC-backed Brisbane, CA
You’re viewing 5 of 25 competitors. Get the full list »

NexaBiome Patents

  • 74

    Total Documents Applications and Grants

  • Total Patents Families

  • 38

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

NexaBiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4136974-A1 Plasma treatment process and apparatus therefor Inactive 20-Aug-2021
AU-2022330362-A1 Plasma treatment process and apparatus therefor Pending 20-Aug-2021
CA-3229310-A1 Plasma treatment process and apparatus therefor Pending 20-Aug-2021
EP-4387454-A1 Plasma treatment process and apparatus therefor Pending 20-Aug-2021
US-20240349731-A1 Plasma treatment process and apparatus therefor Pending 20-Aug-2021 A01N63/40
To view NexaBiome’s complete patent history, request access »

NexaBiome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

NexaBiome FAQs

  • When was NexaBiome founded?

    NexaBiome was founded in 2010.

  • Where is NexaBiome headquartered?

    NexaBiome is headquartered in Glasgow, United Kingdom.

  • What is the size of NexaBiome?

    NexaBiome has 13 total employees.

  • What industry is NexaBiome in?

    NexaBiome’s primary industry is Biotechnology.

  • Is NexaBiome a private or public company?

    NexaBiome is a Private company.

  • What is NexaBiome’s current revenue?

    The current revenue for NexaBiome is .

  • How much funding has NexaBiome raised over time?

    NexaBiome has raised $17.8M.

  • Who are NexaBiome’s competitors?

    APS Biocontrol, Vaiomer, Gangagen Biotechnologies, NovaBiotics, and Second Genome are some of the 25 competitors of NexaBiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »